Tumor antigens such as epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), and carcinoembryonic antigen (CEA) have significant diagnostic and prognostic values as tumor biomarkers. This evidence concerns the gene EGFR and neoplasm.